New developments in the pathogenesis and treatment of steroid-induced osteoporosis.
Manolagas
S C
SC
Division of Endocrinology and Metabolism, Center for Osteoporosis & Metabolic Bone Diseases and the McClellan VA Medical Center, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, USA.
Weinstein
R S
RS
D000818:Animals; D017209:Apoptosis; D015519:Bone Density / Q000187:drug effects; D016723:Bone Remodeling / Q000187:drug effects / Q000502:physiology; D005938:Glucocorticoids / Q000009:adverse effects*; D006801:Humans; D051379:Mice; D010006:Osteoblasts / Q000166:cytology; D010010:Osteoclasts / Q000166:cytology; D010024:Osteoporosis / Q000139:chemically induced* / Q000473:pathology / Q000503:physiopathology / Q000628:therapy*; D051381:Rats
D005938:Glucocorticoids